FDA Allows St. Jude To Resume Transcatheter Heart Valve Trial

St. Jude Medical has received approval from the FDA to resume the investigational device exemption (IDE) trial evaluating its Portico Transcatheter Aortic Valve Implantation System after internal and independent reviews of the previously halted study showed no adverse events associated with the implants.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news